Literature DB >> 2541616

Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma.

Y Ke1, R R Reddel, B I Gerwin, H K Reddel, A N Somers, M G McMenamin, M A LaVeck, R A Stahel, J F Lechner, C C Harris.   

Abstract

Normal human mesothelial (NHM) cells were transfected with a plasmid containing SV40 early region DNA. Individual colonies of transformed cells from several donors were subcultured for periods of 5 to 6 months and 60 to 70 population doublings (PDs) before senescence, in contrast to a culture lifespan of approximately 1 month and 15 PDs for NHM cells. One such culture, designated MeT-5A, escaped senescence and has been passaged continuously for more than 2 years. These cells had a single integrated copy of SV40 early region DNA in their genome, expressed SV40 large T antigen, and exhibited features of mesothelial cells including sensitivity to the cytotoxic effects of asbestos fibers. One year after injection subcutaneously or intraperitoneally in athymic nude mice, these cells remain nontumorigenic, and therefore are a potential model system for in vitro fiber carcinogenesis studies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541616      PMCID: PMC1879894     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

Review 1.  Control of growth of mammalian cells in cell culture.

Authors:  R W Holley
Journal:  Nature       Date:  1975-12-11       Impact factor: 49.962

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Dissimilar peptide growth factors can induce normal human mesothelial cell multiplication.

Authors:  M A Laveck; A N Somers; L L Moore; B I Gerwin; J F Lechner
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

4.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

5.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

6.  Phagocytosis of chrysotile fibers by pleural mesothelial cells in culture.

Authors:  M C Jaurand; H Kaplan; J Thiollet; M C Pinchon; J F Bernaudin; J Bignon
Journal:  Am J Pathol       Date:  1979-03       Impact factor: 4.307

7.  Cloning.

Authors:  L C Reid
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

8.  Cell culture characterization: monitoring for cell identification.

Authors:  W D Peterson; W F Simpson; B Hukku
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

9.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  44 in total

1.  Telomerase activity in pleural malignant mesotheliomas.

Authors:  Amy Y M Au; Torben Hackl; Thomas R Yeager; Scott B Cohen; Harvey I Pass; Curtis C Harris; Roger R Reddel
Journal:  Lung Cancer       Date:  2011-01-31       Impact factor: 5.705

2.  Immunolocalization of caveolin-1 in rat and human mesothelium.

Authors:  Christopher J von Ruhland; Lee Campbell; Mark Gumbleton; Bharat Jasani; Geoffrey R Newman
Journal:  J Histochem Cytochem       Date:  2004-11       Impact factor: 2.479

Review 3.  In vitro experimental models of mesothelioma revisited.

Authors:  Anand Singh; Nathanael Pruett; Chuong D Hoang
Journal:  Transl Lung Cancer Res       Date:  2017-06

4.  A cobblestone cell isolated from the human omentum: the mesothelial cell; isolation, identification, and growth characteristics.

Authors:  A Pronk; P Leguit; A A Hoynck van Papendrecht; E Hagelen; T J van Vroonhoven; H A Verbrugh
Journal:  In Vitro Cell Dev Biol       Date:  1993-02

Review 5.  Asbestos, Simian virus 40 and malignant mesothelioma.

Authors:  S C Stenton
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139

6.  Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers.

Authors:  J C Pache; Y M Janssen; E S Walsh; T R Quinlan; C L Zanella; R B Low; D J Taatjes; B T Mossman
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

7.  Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.

Authors:  Gavin J Gordon; Graham N Rockwell; Roderick V Jensen; James G Rheinwald; Jonathan N Glickman; Joshua P Aronson; Brian J Pottorf; Matthew D Nitz; William G Richards; David J Sugarbaker; Raphael Bueno
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

8.  Differential effects of tumor necrosis factor and asbestos fibers on manganese superoxide dismutase induction and oxidant-induced cytotoxicity in human mesothelial cells.

Authors:  P Pietarinen-Runtti; K O Raivio; K Linnainmaa; A Ekman; M Saksela; V L Kinnula
Journal:  Cell Biol Toxicol       Date:  1996-06       Impact factor: 6.691

9.  Overexpression of microRNA miR-30a or miR-191 in A549 lung cancer or BEAS-2B normal lung cell lines does not alter phenotype.

Authors:  Santosh Kumar Patnaik; Eric Kannisto; Sai Yendamuri
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

10.  Spontaneously immortalized mouse mesothelial cells display characteristics of malignant transformation.

Authors:  A L Sherwood; S E Mutsaers; V K Peeva; C Robinson; C J DeSilva; N R Swanson; R A Lake
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.